Abhishek Kashyap

Abhishek Kashyap is an accomplished professional in the field of cancer immunology and immune modulation, currently serving as Director at Boehringer Ingelheim since May 2020, where responsibilities include leading preclinical activities related to cancer immunology. Previously, Abhishek held positions as Project Leader and Research Scientist at University Hospital Basel, overseeing industry-academia partnerships focused on novel cancer therapies. Abhishek also functioned as a Life Science Consultant specializing in immuno-oncology and contributed to research collaborations at prominent institutions such as Massachusetts General Hospital and Harvard University. Abhishek's academic background includes a PhD in Cell and Molecular Biology from Queensland University of Technology, complemented by a Master's in Medical Biotechnology and a Bachelor's in Biotechnology.